Clinical Trial Update: Effect of Aspirin and Folic Acid for Sudden Sensorineural Hearing Loss [Phase 3]

View source ↗

Summary

Phase 3 trial investigates aspirin plus folic acid for sudden sensorineural hearing loss. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Sensorineural Hearing Loss

Drugs mentioned

• Aspirin (Aspirin)
• folic acid (folic acid)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Sudden Sensorineural Hearing Loss | Phase 3 | Status: NOT_YET_RECRUITING